| Product Code: ETC4639752 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Ireland Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F |
3.6 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Ireland Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Growth in research and development activities in cell and gene therapy |
4.2.3 Favorable regulatory environment in Ireland |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy manufacturing |
4.3.2 Limited availability of skilled workforce |
4.3.3 Stringent regulatory requirements for manufacturing processes |
5 Ireland Contract Cell and Gene Therapy Manufacturing Market Trends |
6 Ireland Contract Cell and Gene Therapy Manufacturing Market Segmentations |
6.1 Ireland Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2021-2031F |
6.1.3 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2021-2031F |
6.2 Ireland Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2021-2031F |
6.2.3 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2021-2031F |
6.2.4 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Herpetological Diseases, 2021-2031F |
6.2.5 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021-2031F |
7 Ireland Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Ireland Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Ireland Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 Ireland Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Number of clinical trials utilizing cell and gene therapy in Ireland |
8.2 Investment in infrastructure for cell and gene therapy manufacturing facilities |
8.3 Percentage of successful technology transfers in the market |
9 Ireland Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Ireland Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F |
9.2 Ireland Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Ireland Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Ireland Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Ireland Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |